NCT01767597 Application of HBV Rapid Tests as a Tool for Wide-Use Screening Status COMPLETED Phase NA
NCT01766726 Effects of Newly-Initiated QUAD Therapy on Aortic/Coronary Inflammation in ART-Naïve Infected Patients Status COMPLETED Phase N/A
NCT01761643 CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM Status COMPLETED Phase PHASE4
NCT01759511 Long-Term Safety Study of GS-6624 in Adults With Idiopathic Pulmonary Fibrosis (IPF) Status TERMINATED Phase PHASE2
NCT01756482 Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV) Status COMPLETED Phase PHASE2
NCT01754428 Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age Status COMPLETED Phase N/A
NCT01751555 Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection Status COMPLETED Phase PHASE4
NCT01745822 Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand Status COMPLETED Phase PHASE3
NCT01740791 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection Status COMPLETED Phase PHASE1
NCT01737047 The Effects of Ageing on the 'Pharmacokinetic and Clinical Observations in People Over Fifty' Status COMPLETED Phase N/A
NCT01732926 Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas Status TERMINATED Phase PHASE3
NCT01732913 Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas Status TERMINATED Phase PHASE3
NCT01730638 ImmunoTEP for Patients With Medullary Thyroid Carcinoma. Status COMPLETED Phase PHASE1/PHASE2
NCT01730612 ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA Status COMPLETED Phase PHASE1/PHASE2
NCT01728207 Phase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLL Status TERMINATED Phase PHASE1
NCT01726517 Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects Status COMPLETED Phase PHASE2
NCT01721109 Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents Status COMPLETED Phase PHASE2/PHASE3